EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade

Julian S Wanner iD, Maren Krafft, Teemu Niiranen, Dominic S Zimmerman, FinnGen, Patrick T Ellinor iD, Girish Nadkarni iD, Sean J Jurgens iD, Joel Rämö iD, Henrike O Heyne iD

Circulation · 2025

DOI: 10.1161/circulationaha.125.075057 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Circulation, 2025. Verfasst von Julian S Wanner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Germany (J.S.W., M.K., H.O.H.). Hauptthemen laut MEDLINE: NAV1.5 Voltage-Gated Sodium Channel, Arrhythmias, Cardiac, Sodium Channel Blockers, Atrial Fibrillation. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atrial fibrillation and other cardiac arrhythmias pose a major public health burden, but prevention remains difficult. We investigated a genetic variant that we found to act like a natural lifelong cardiac sodium channel blockade. METHODS: We studied the impact of the Finnish-enriched SCN5A missense variant (rs45620037 [T220I]) on cardiac arrhythmias, associated mortality, and ECG phenotypes in a multicohort observational study with >1 million individuals across 3 cohorts (FinnGen, UK Biobank, and Health 2000). RESULTS: We identified protective effects of T220I on multiple common cardiac arrhythmias, most notably atrial fibrillation (cause-specific hazard ratio [HR], 0.56 [95% CI, 0.50–0.63]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NAV1.5 Voltage-Gated Sodium ChannelArrhythmias, CardiacSodium Channel BlockersAtrial FibrillationHumansMaleFemaleMiddle AgedAgedFinlandMutation, MissenseElectrocardiographyAdult

Stichwörter der Autor:innen

arrhythmias, cardiacatrial fibrillationbradycardiatachycardia

Substanzen

NAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanSodium Channel Blockers

Autor:innen und Institutionen

  • Hasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Germany (J.S.W., M.K., H.O.H.).
  • Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland (J.S.W., J.R., H.O.H.).
  • Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland (T.N.).
  • Department of Internal Medicine, Turku University Hospital and University of Turku, Finland (T.N.).
  • Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure & Arrhythmias, Amsterdam UMC, University of Amsterdam, the Netherlands (D.S.Z., S.J.J.).
  • Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (P.T.E., S.J.J., J.R.).

ORCID-Profile: Julian S Wanner, Patrick T Ellinor, Girish Nadkarni, Sean J Jurgens, Joel Rämö, Henrike O Heyne

Zitieren

APA

Wanner, J. S., Krafft, M., Niiranen, T., Zimmerman, D. S., FinnGen, Ellinor, P. T., Nadkarni, G., Jurgens, S. J., Rämö, J., & Heyne, H. O. (2025). Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade. Circulation. https://doi.org/10.1161/circulationaha.125.075057

Vancouver

Wanner JS, Krafft M, Niiranen T, Zimmerman DS, FinnGen, Ellinor PT, et al. Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade. Circulation. 2025. doi:10.1161/circulationaha.125.075057

BibTeX
@article{Wanner2025,
  author = {Wanner, Julian S and Krafft, Maren and Niiranen, Teemu and Zimmerman, Dominic S and FinnGen and Ellinor, Patrick T and Nadkarni, Girish and Jurgens, Sean J and Rämö, Joel and Heyne, Henrike O},
  title = {Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade},
  journal = {Circulation},
  year = {2025},
  doi = {10.1161/circulationaha.125.075057}
}
Kostenlos starten →